1. Home
  2. ICUCW vs ALH Comparison

ICUCW vs ALH Comparison

Compare ICUCW & ALH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • ALH
  • Stock Information
  • Founded
  • ICUCW N/A
  • ALH 1908
  • Country
  • ICUCW United States
  • ALH United States
  • Employees
  • ICUCW 18
  • ALH N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • ALH Industrial Machinery/Components
  • Sector
  • ICUCW Health Care
  • ALH Industrials
  • Exchange
  • ICUCW Nasdaq
  • ALH Nasdaq
  • Market Cap
  • ICUCW N/A
  • ALH N/A
  • IPO Year
  • ICUCW 2021
  • ALH 2025
  • Fundamental
  • Price
  • ICUCW $0.04
  • ALH $26.50
  • Analyst Decision
  • ICUCW
  • ALH
  • Analyst Count
  • ICUCW 0
  • ALH 0
  • Target Price
  • ICUCW N/A
  • ALH N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • ALH 2.1M
  • Earning Date
  • ICUCW N/A
  • ALH 11-13-2025
  • Dividend Yield
  • ICUCW N/A
  • ALH N/A
  • EPS Growth
  • ICUCW N/A
  • ALH N/A
  • EPS
  • ICUCW N/A
  • ALH 0.45
  • Revenue
  • ICUCW N/A
  • ALH $1,616,188,000.00
  • Revenue This Year
  • ICUCW N/A
  • ALH N/A
  • Revenue Next Year
  • ICUCW N/A
  • ALH N/A
  • P/E Ratio
  • ICUCW N/A
  • ALH $58.68
  • Revenue Growth
  • ICUCW N/A
  • ALH 17.43
  • 52 Week Low
  • ICUCW N/A
  • ALH $23.50
  • 52 Week High
  • ICUCW N/A
  • ALH $27.00
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW 51.59
  • ALH N/A
  • Support Level
  • ICUCW $0.03
  • ALH N/A
  • Resistance Level
  • ICUCW $0.04
  • ALH N/A
  • Average True Range (ATR)
  • ICUCW 0.01
  • ALH 0.00
  • MACD
  • ICUCW 0.00
  • ALH 0.00
  • Stochastic Oscillator
  • ICUCW 76.22
  • ALH 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: